OAKLAND, Calif. — Johnson & Johnson must pay $29 million to a woman who claimed its baby powder gave her terminal cancer, a California jury ruled Wednesday.
A Superior Court jury in Oakland found the world’s largest health care company mainly liable for Teresa Leavitt’s mesothelioma. The verdict said that the baby powder was a “substantial contributing factor” in her illness.
Her suit is one of many that link cancers to asbestos in Johnson & Johnson’s talc-based products and contend that the company concealed the health risk for decades.
Requests for comment from the New Jersey-based comment were not immediately answered.
Johnson & Johnson is facing some 13,000 similar lawsuits around the country.
The company has insisted that its talc-based products are demonstrably safe but it has lost a string of court cases.
Last year, a Los Angeles jury awarded $25.7 million to a woman who blamed her cancer on the powder.
A jury in Missouri last year awarded $4.69 million to 22 women.
Johnson & Johnson’s stock price dropped nearly 2 percent after hours on Wednesday before recovering to close at $139.41.
- California jury awards $29M in baby powder cancer case
- Roundup weed killer: Jury says it's a major factor in man's cancer
- Jury awards $29M in J&J baby powder cancer case
- Johnson & Johnson hit with $29M verdict in case over talc, asbestos
- Woman with cancer who sued J&J awarded $29M by California jury
- Jury orders Johnson & Johnson to pay $29M in cancer lawsuit
- Stocks little changed as Boeing shares stabilize
- Stocks little changed on trade concerns, home sales miss